<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, little high grade evidence for cure, life extension, disease modification or palliation achieved by pulmonary metastasectomy exists </plain></SENT>
<SENT sid="1" pm="."><plain>This has prompted the pulmonary metastasectomy in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (PulMiCC) trial </plain></SENT>
<SENT sid="2" pm="."><plain>Reappraisal of the biological facts on colorectal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> may, however, shed light on an alternative avenue of clinical management </plain></SENT>
<SENT sid="3" pm="."><plain>Early <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, short doubling time and a short disease-free interval are <z:hpo ids='HP_0000001'>all</z:hpo> associated with poor clinical outcomes </plain></SENT>
<SENT sid="4" pm="."><plain>Selecting who will be cured (i.e. no occult <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>) remains the holy grail for pulmonary metastasectomy surgery </plain></SENT>
<SENT sid="5" pm="."><plain>Serial CT scans can be utilized to calculate the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> doubling time by volumetric analysis </plain></SENT>
<SENT sid="6" pm="."><plain>Knowing the doubling time and size of the largest <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, which by definition is the first cell that has successfully spread from the primary site, the time of initial <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> can be predicted </plain></SENT>
<SENT sid="7" pm="."><plain>More importantly, using the doubling time, calculating the time interval from the primary surgery to the point at which <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0153676" disease_type="Neoplastic Process" abbrv="">pulmonary metastases</z:e> are visible should be possible </plain></SENT>
<SENT sid="8" pm="."><plain>Perhaps watchful waiting, with interval CT scanning, followed by pulmonary metastasectomy should be utilized, rather than clinical opinion or randomization in a trial based upon first presentation </plain></SENT>
</text></document>